Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence

Inclusion Criteria: * • Signed informed consent obtained prior to any study specific assessments and procedures * Eastern Cooperative Oncology Group (ECOG) performance status 0-2 * Women or men diagnosed with stage 0-III hormone receptor positive (estrogen receptor positive \[ER\] and /or progesterone receptor \[PR\] positive) breast cancer \* Staging for eligibility should utilize the most recent American Joint Committee on Cancer (AJCC) breast cancer staging version * Patients (Pts) must have undergone breast surgery for their diagnosis of breast cancer * Adjuvant endocrine therapy has been prescribed by their treating physician \* Patients may receive concurrent adjuvant radiation therapy plus endocrine therapy in the post-operative setting * Have a cell phone with text messaging ability * Have access to a computer, tablet, or smart phone to complete electronic surveys * Patient must be willing to setup an online Jefferson MyChart account * Patients who have been on endocrine therapy for more than 4 years Exclusion Criteria: * Pts with stage IV metastatic breast cancer * Patients unable to participate in patient portal communication (e.g. do not have either a smart phone, laptop, access to a computer and/ or access to a device with a webcam) * Pts who are non-English speaking and English illiterate